Emerging Treatments in Oligometastatic and Bladder Cancers

This chapter explores the latest developments in oncology, particularly in oligometastatic disease and prostate cancer therapies, including PSMA-based treatments. It also highlights new efficacy outcomes and survival data in bladder cancer trials, showcasing the rapidly evolving landscape of cancer treatment options.